# FDA 483 - Institute for Human Reproduction (IHR), SC - February 25, 2020

Source: https://www.keypedia.com/records/483/institute-for-human-reproduction-ihr-sc/9642218f-538b-4209-bf91-14a27e531511

> FDA 483 for Institute for Human Reproduction (IHR), SC on February 25, 2020. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Institute for Human Reproduction (IHR), SC
- Inspection Date: 2020-02-25
- Product Type: other
- Office Name: Chicago District Office
- Summary: An FDA inspection of the Institute for Human Reproduction (IHR) in Chicago, IL, revealed significant deficiencies in donor screening practices for human reproductive cells and tissues. The firm failed to screen donors for Zika virus risk factors and lacked updated procedures for donor eligibility determination. Additionally, records did not properly document laboratory certification for communicable disease testing.

## Related Documents

- [483 - 2023-10-25](https://www.keypedia.com/records/483/institute-for-human-reproduction-ihr-sc/dbc6f0ca-7402-4e58-a19b-ce9ec3258acb)

## Related Officers

- [Lewis K. Antwi](https://www.keypedia.com/people/lewis-k-antwi/8ab4f1c7-8b5b-4556-98a4-6edc3bc49470)
- [Lee Terry Moore](https://www.keypedia.com/people/lee-terry-moore/eed5f225-7c3d-467a-8efb-7bb2e809c6b6)

Company: https://www.keypedia.com/companies/institute-for-human-reproduction-ihr-sc/03a1fa1e-26f4-4bf3-a2a3-66ce0542101e

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669